Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

被引:89
|
作者
Stassen, HH [1 ]
Angst, J [1 ]
DeliniStula, A [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD,CNS MED RES,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1055/s-2007-979551
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The onset of action of antidepressant drugs was investigated on the basis of two independent, multicenter, double-blind studies, comparing amitriptyline (N = 120), oxaprotiline (N = 120), imipramine (N = 506) and moclobemide (N = 580) with placebo (N = 189 /+ 191). Highly significant differences between the active drugs and placebo were found with respect to the total number of improvers and the total number of responders. In addition, significant differences between treatment modalities showed up in both the percentage rate and the time distribution of premature withdrawals. However, among improvers, the distribution of time spans to onset of improvement was found to be independent of treatment modality, indicated by virtual ly identical cumulative percentages of improvers over the whole observation period. This picture of treatment-independent improvement rates was essentially the same for the HAMD, HAMA and ZUNG assessments, except for a significant time lag between observerratings and selfratings. Specifically, our analyses revealed no evidence for a delayed onset of action of various antidepressants with large biochemical and pharmacological differences when compared to placebo. The early onset of improvement was highly predictive of later outcome: on average, 70% of patients showing improvement within the first 14 days became responders. Differences between active treatments and placebo emerged within the first five days and reached a point of maximum distinction around day 14. After this time point, differences between treatment modalities remained constant until the end of the observation period. Not more than 20 - 25% of patients were, on average, ''true'' drug responders, thus suggesting that the therapeutic qualities of antidepressants do not lie in the suppression of symptoms, but rather relate to their ability to elicit and maintain certain conditions which enable recovery in a subgroup of patients who would otherwise remain nonresponders.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [1] Delayed onset of action of antidepressant drugs? Survey of recent results
    Stassen, HH
    Angst, J
    DeliniStula, A
    EUROPEAN PSYCHIATRY, 1997, 12 (04) : 166 - 176
  • [2] Meta-analyses and antidepressant prescribing
    Lenox-Smith, Alan
    D'yachkova, Yulia
    Deberdt, Walter
    Raskin, Joel
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (04) : 629 - 630
  • [3] Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses
    Desaunay, Pierre
    Eude, Lea-Gabrielle
    Dreyfus, Michel
    Alexandre, Ceneric
    Fedrizzi, Sophie
    Alexandre, Joachim
    Uguz, Faruk
    Guenole, Fabian
    PEDIATRIC DRUGS, 2023, 25 (03) : 247 - 265
  • [4] Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses
    Pierre Desaunay
    Léa-Gabrielle Eude
    Michel Dreyfus
    Cénéric Alexandre
    Sophie Fedrizzi
    Joachim Alexandre
    Faruk Uguz
    Fabian Guénolé
    Pediatric Drugs, 2023, 25 : 247 - 265
  • [5] Second-step strategies in antidepressant pharmacotherapy: Results of current meta-analyses
    Krabs, Marlene
    Bschor, Tom
    Henssler, Jonathan
    Baethge, Christopher
    NERVENARZT, 2025, 96 (02): : 138 - 145
  • [6] Antidepressant light therapy for bipolar patients: A meta-analyses
    Dallaspezia, Sara
    Benedetti, Francesco
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 274 : 943 - 948
  • [7] SUICIDALITY: RESULTS OF RECENT META-ANALYSES
    不详
    KONSULTATIVNAYA PSIKHOLOGIYA I PSIKHOTERAPIYA-COUNSELING PSYCHOLOGY AND PSYCHOTHERAPY, 2023, 31 (02): : 171 - 176
  • [8] Meta-analyses of published results are unreliable
    Buyse, M
    Carlson, RW
    Piedbois, P
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1646 - 1647
  • [9] Meta-analyses of standard tests for screening antidepressant and anxiolytic effects
    Stukalin, Y.
    Einat, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S396 - S396
  • [10] Can we trust the results of meta-analyses? A systematic approach to sensitivity analysis in meta-analyses
    Elvik, R
    STATISTICAL METHODS; HIGHWAY SAFETY DATA, ANALYSIS, AND EVALUATION; OCCUPANT PROTECTION; SYSTEMATIC REVIEWS AND META-ANALYSIS, 2005, (1908): : 221 - 229